Posts

A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace chief executive Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price.

Global healthcare communications company SCIRIS is delighted to announce the appointment of Isaac Batley as new CEO.

Biogen Inc. on Thursday tapped former Sanofi boss Christopher Viehbacher as its new chief executive, betting on an industry veteran to help the U.S. drugmaker put behind it a series of setbacks for Alzheimer’s drug Aduhelm.

Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while confirming he was unlikely to renew his contract next year.

Bayer CEO Werner Baumann may be on the way out. For the past several years, Baumann has been in the sights of angry shareholders but has evaded an ouster. That soon may be over.